Cargando…

The epidemiology of cardiovascular disease in the UK 2014

Cardiovascular disease (CVD) presents a significant burden to the UK. This review presents data from nationally representative datasets to provide up-to-date statistics on mortality, prevalence, treatment and costs. Data focus on CVD as a whole, coronary heart disease (International Classification o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatnagar, Prachi, Wickramasinghe, Kremlin, Williams, Julianne, Rayner, Mike, Townsend, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515998/
https://www.ncbi.nlm.nih.gov/pubmed/26041770
http://dx.doi.org/10.1136/heartjnl-2015-307516
_version_ 1782383001497239552
author Bhatnagar, Prachi
Wickramasinghe, Kremlin
Williams, Julianne
Rayner, Mike
Townsend, Nick
author_facet Bhatnagar, Prachi
Wickramasinghe, Kremlin
Williams, Julianne
Rayner, Mike
Townsend, Nick
author_sort Bhatnagar, Prachi
collection PubMed
description Cardiovascular disease (CVD) presents a significant burden to the UK. This review presents data from nationally representative datasets to provide up-to-date statistics on mortality, prevalence, treatment and costs. Data focus on CVD as a whole, coronary heart disease (International Classification of Diseases (ICD):I20–25) and cerebrovascular disease (ICD:I60–69); however, where available, other cardiovascular conditions are also presented. In 2012, CVD was the most common cause of death in the UK for women (28% of all female deaths), but not for men, where cancer is now the most common cause of death (32% of all male deaths). Mortality from CVD varies widely throughout the UK, with the highest age-standardised CVD death rates in Scotland (347/100 000) and the North of England (320/100 000 in the North West). Prevalence of coronary heart disease is also highest in the North of England (4.5% in the North East) and Scotland (4.3%). Overall, around three times as many men have had a myocardial infarction compared with women. Treatment for CVD is increasing over time, with prescriptions and operations for CVD having substantially increased over the last two decades. The National Health Service in England spent around £6.8 billion on CVD in 2012/2013, the majority of which came from spending on secondary care. Despite significant declines in mortality in the UK, CVD remains a considerable burden, both in terms of health and costs. Both primary and secondary prevention measures are necessary to reduce both the burden of CVD and inequalities in CVD mortality and prevalence.
format Online
Article
Text
id pubmed-4515998
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-45159982015-08-03 The epidemiology of cardiovascular disease in the UK 2014 Bhatnagar, Prachi Wickramasinghe, Kremlin Williams, Julianne Rayner, Mike Townsend, Nick Heart Review Cardiovascular disease (CVD) presents a significant burden to the UK. This review presents data from nationally representative datasets to provide up-to-date statistics on mortality, prevalence, treatment and costs. Data focus on CVD as a whole, coronary heart disease (International Classification of Diseases (ICD):I20–25) and cerebrovascular disease (ICD:I60–69); however, where available, other cardiovascular conditions are also presented. In 2012, CVD was the most common cause of death in the UK for women (28% of all female deaths), but not for men, where cancer is now the most common cause of death (32% of all male deaths). Mortality from CVD varies widely throughout the UK, with the highest age-standardised CVD death rates in Scotland (347/100 000) and the North of England (320/100 000 in the North West). Prevalence of coronary heart disease is also highest in the North of England (4.5% in the North East) and Scotland (4.3%). Overall, around three times as many men have had a myocardial infarction compared with women. Treatment for CVD is increasing over time, with prescriptions and operations for CVD having substantially increased over the last two decades. The National Health Service in England spent around £6.8 billion on CVD in 2012/2013, the majority of which came from spending on secondary care. Despite significant declines in mortality in the UK, CVD remains a considerable burden, both in terms of health and costs. Both primary and secondary prevention measures are necessary to reduce both the burden of CVD and inequalities in CVD mortality and prevalence. BMJ Publishing Group 2015-08-01 2015-06-03 /pmc/articles/PMC4515998/ /pubmed/26041770 http://dx.doi.org/10.1136/heartjnl-2015-307516 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Review
Bhatnagar, Prachi
Wickramasinghe, Kremlin
Williams, Julianne
Rayner, Mike
Townsend, Nick
The epidemiology of cardiovascular disease in the UK 2014
title The epidemiology of cardiovascular disease in the UK 2014
title_full The epidemiology of cardiovascular disease in the UK 2014
title_fullStr The epidemiology of cardiovascular disease in the UK 2014
title_full_unstemmed The epidemiology of cardiovascular disease in the UK 2014
title_short The epidemiology of cardiovascular disease in the UK 2014
title_sort epidemiology of cardiovascular disease in the uk 2014
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515998/
https://www.ncbi.nlm.nih.gov/pubmed/26041770
http://dx.doi.org/10.1136/heartjnl-2015-307516
work_keys_str_mv AT bhatnagarprachi theepidemiologyofcardiovasculardiseaseintheuk2014
AT wickramasinghekremlin theepidemiologyofcardiovasculardiseaseintheuk2014
AT williamsjulianne theepidemiologyofcardiovasculardiseaseintheuk2014
AT raynermike theepidemiologyofcardiovasculardiseaseintheuk2014
AT townsendnick theepidemiologyofcardiovasculardiseaseintheuk2014
AT bhatnagarprachi epidemiologyofcardiovasculardiseaseintheuk2014
AT wickramasinghekremlin epidemiologyofcardiovasculardiseaseintheuk2014
AT williamsjulianne epidemiologyofcardiovasculardiseaseintheuk2014
AT raynermike epidemiologyofcardiovasculardiseaseintheuk2014
AT townsendnick epidemiologyofcardiovasculardiseaseintheuk2014